| Synthesis and biological evaluation of 3-amino-1, 2, 4-triazole derivatives as potential anticancer compounds O Grytsai, O Valiashko, M Penco-Campillo, M Dufies, A Hagege, ... Bioorganic chemistry 104, 104271, 2020 | 56 | 2020 |
| VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells M Penco-Campillo, Y Comoglio, ÁJ Feliz Morel, R Hanna, J Durivault, ... Communications Biology 3 (1), 579, 2020 | 9 | 2020 |
| Advanced age in humans and mouse models of glioblastoma show decreased survival from extratumoral influence M Johnson, A Bell, KL Lauing, E Ladomersky, L Zhai, M Penco-Campillo, ... Clinical Cancer Research 29 (23), 4973-4989, 2023 | 2 | 2023 |
| Author Correction: VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells M Penco-Campillo, Y Comoglio, ÁJ Feliz Morel, R Hanna, J Durivault, ... Communications biology 3 (1), 758, 2020 | 2 | 2020 |
| Angiogenesis and lymphangiogenesis in medulloblastoma development M Penco-Campillo, G Pages, S Martial Biology 12 (7), 1028, 2023 | 1 | 2023 |
| Targeting of the ELR+ CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas M Penco-Campillo, C Molina, P Piris, N Soufi, M Carré, ... Cells 11 (23), 3933, 2022 | 1 | 2022 |
| Age-stratified comorbid and pharmacologic analysis of patients with glioblastoma EE Rabin, J Huang, M Kim, A Mozny, KL Lauing, M Penco-Campillo, ... Brain, Behavior, & Immunity-Health 38, 100753, 2024 | | 2024 |
| Le VEGFC et les récepteurs CXCR1/2: des cibles pertinentes pour le traitement des médulloblastomes pédiatriques M Penco-Campillo Université Côte d'Azur, 2022 | | 2022 |
